<!DOCTYPE html>
<html lang="en"><!-- InstanceBegin template="/Templates/page_layout.dwt" codeOutsideHTMLIsLocked="false" -->
<head>
<meta charset="utf-8" />

<!-- InstanceBeginEditable name="doctitle" -->

<title>VCU Office of Research and Innovation - VCU Innovation Gateway: “Cannabinoid Receptor Drug for Lung Delivery with Phase I/II Data”</title>

<!-- InstanceEndEditable -->

<meta name="viewport" content="width=device-width, initial-scale=1.0" /><!--iPhone image scaling fix-->

<link href="../../css/page_layout.css" rel="stylesheet" type="text/css" media="all"/>
<link href="../../css/media_queries.css" rel="stylesheet" type="text/css" media="all"/>
<link rel="stylesheet" href="../../css/print.css" type="text/css" media="print" />
<link href='http://fonts.googleapis.com/css?family=Enriqueta:400,700' rel='stylesheet' type='text/css'>

<link REL="SHORTCUT ICON" HREF="http://www.research.vcu.edu/favicon.ico"> <!--icon in the address bar...do NOT delete-->
   
<script type="text/javascript" src="http://www.research.vcu.edu/js/respond.js"></script>

<!--[if IE 6]>
	<link a href="http://www.research.vcu.edu/css/IE_fixes/IE6.css" rel="stylesheet" type="text/css" media="all"/>
	<script type="text/javascript" src="http://www.research.vcu.edu/js/iehoverfix.js"></script>
<![endif]-->

<!--[if IE 7]>
	<link a href="http://www.research.vcu.edu/css/IE_fixes/IE7.css" rel="stylesheet" type="text/css" media="all"/>
	<script type="text/javascript" src="http://www.research.vcu.edu/js/iehoverfix.js"></script>
<![endif]-->

<!-- InstanceBeginEditable name="head" -->

<style>

#top_nav #nav_tech a {
		color:#fff;
		border-left:3px solid #fff;
		border-right:3px solid #fff;
	}

h2 {
	text-align:center;
	padding-top:1em;
}

.figure {
	text-align:center;
	float:right;
}

@media screen and (max-width:480px) {
	.figure {
		float:none;
	}
}

</style>

<!-- InstanceEndEditable -->

</head>

<body>

<div id="page">
	<div id="header">
    	<div id="logo_bar">
        	<a href="http://www.vcu.edu" target="_blank"><img src="../../images/identity_header/branding_bar.png" alt="VCU bar logo" id="vcu_logo_desktop" /></a>
            <a href="http://www.vcu.edu" target="_blank"><img src="http://identity.vcu.edu/widgets/branding/black/responsive/images/vcuseal.gif" alt="VCU logo" id="vcu_logo_mobile" /></a>
       	</div>
        <span id="skip_link"><a href="#mainContent">skip to main content</a></span>
        <div id="identity_search">
        	<div id="vcu_research">
            	<a href="../../index.htm"><img src="../../images/identity_header/office_research.png" alt="Office of Research and Innovation" id="office_research" /></a>
        	</div><!--end vcu_research-->
			<div id="search">
  				<form action="http://search.vcu.edu/search" method="get">
  				<input type="text" name="q" id="searchField" placeholder="Search" />
                <input type="hidden" name="query" value="">
              	<input type="hidden" name="proxystylesheet" value="research">
          		<input type="hidden" name="output" value="xml_no_dtd">
               	<input type="hidden" name="client" value="research"> 
              	<input type="hidden" name="sort" value="date:D:L:d1">
               	<input type="hidden" name="entqr" value="3">
              	<input type="hidden" name="oe" value="UTF-8">
               	<input type="hidden" name="ie" value="UTF-8">
               	<input type="hidden" name="ud" value="1">
                <input type="hidden" name="site" value="research-main">
  				<label for="searchField">Search for:</label>
  				<button class="search_btn" type="submit"></button>
</form>
           	</div>
  		</div><!--end identity_search-->
  
<div id="top_nav_container">
<div id="top_nav">
	<ul>
		<li id="nav_prop_awards"><a href="../../osp/index.htm">Proposals &amp; Awards</a></li>
		<li id="nav_human"><a href="../../human_research/index.htm">Human Research</a></li>
        <li id="nav_animal"><a href="https://www.vcu.edu/research/acup/index.htm">Animal Research</a></li>
        <li id="nav_tech"><a href="../index.htm">Innovation</a></li>
        <li id="nav_conduct"><a href="../../research_conduct/index.htm">Researcher Conduct</a></li>
	</ul>
</div>
</div> <!-- end top_nav_container -->
</div><!--end header-->
<div id="main">
	<div id="page_head">            
            <div id="heading_bar">
				<!-- InstanceBeginEditable name="heading bar" -->            	
                <h1>VCU Innovation Gateway</h1>
				<!-- InstanceEndEditable -->     	
            </div><!--end heading_bar-->
            
            <div id="head_image">
		    <!-- InstanceBeginEditable name="head image" -->            	
                <img src="../../images/head_images/ott.jpg" alt="image of the word innovation in the dictionary" />
                <!-- InstanceEndEditable -->            
          	</div><!--end head image-->
    	</div><!--end page_head-->
	<div id="content">       
      <div id="content_text">
      <a id="mainContent"></a>
<!-- InstanceBeginEditable name="content" -->

<p id="breadcrumbs"><a href="../index.htm">VCU Innovation Gateway</a> &raquo; <a href="../technologies_index.htm">Technologies Available for Licensing</a></p>

<h2>"Cannabinoid Receptor  Drug for Lung Delivery with Phase I/II Data"<span id="tech_number">VCU #98-70</span></h2>

	<div id="sidebar">
    	<div id="app_advant">
           	
            <p class="style1">Applications</p>
            	<p class="no_margin">Treatment for:</p>
                	<ul>
                    	<li>Nausea</li>
                        <li>Emesis</li>
                        <li>Decreased appetite</li>
                        <li>Migraine</li>
                        <li>Neuropathic pain</li>
                        <li>Anxiety</li>
                        <li>Seizures and epilepsy</li>
                        <li>Inflammation</li>
                  	</ul>
  
              	<p class="style1">Advantages</p>
                	<ul>
                    	<li>Faster and improved  systemic delivery compared to oral administration</li>
                        <li>Pharamceutically-acceptable  alternative to inhaled marijuana</li>
                   	</ul>
        </div>
        
        <div id="inv_contact">
        
        	<p class="style1">Inventors</p>
            	<ul class="list_no_bullets">
                	<li><a href="http://www.pharmacy.vcu.edu/pharmaceutics/facdetail.aspx?id=96" target="_blank">Joanne Peart, Ph.D.</a></li>
                    <li><a href="http://www.pharmacy.vcu.edu/pharmaceutics/facdetail.aspx?id=52" target="_blank">Peter Byron, Ph.D.</a></li>
                    <li>Billy Martin, Ph.D.</li>
                    <li><a href="http://www.people.vcu.edu/~alichtma/" target="_blank">Aron Lichtman, Ph.D.</a></li>
               	</ul>
                
        	<p class="style1">Contact</p>
            	<ul class="list_no_bullets">
                	<li><strong>Wendy M. Reid, Ph.D.</strong></li>
                    <li>Licensing Associate</li>
                    <li><a href="mailto:wmreid@vcu.edu">wmreid@vcu.edu </a></li>
                    <li>(804) 827-2213</li>
               	</ul>
           	<a href="pdf/PEA-98-70.pdf" target="_blank">Click here for PDF Version</a>
        </div>
  	</div>

  <p class="licensable_tech">Market Need</p>

  <p>Chronic pain is an emerging public health issue, particularly in view of the aging populations of industrialized nations.  Over 38 million Americans suffer from chronic pain.</p>

  <p class="licensable_tech">Technology  Summary</p>

  <p>A pressurized metered dose inhaler (pMDI) for the pulmonary delivery of delta-9-tetrahydrocannabinol (THC)  supported by an extensive patent estate, inhalation toxicity testing in rats  and dogs and Phase 1 and early Phase II clinical results in humans.</p>

  <ul>

    <li>Pharmacology: cannabinoid receptor agonist </li>

    <li>Route of administration: oral inhalation</li>

    <li>Dosage form: CFC-free pressurized metered dose inhaler (multiple strengths)</li>

  </ul>

  <p>Potential  use includes multiple therapeutic indications and neuroprotection. </p>

<p class="licensable_tech">Clinical Testing</p>

	<div class="figure"><img src="images/PEA-98-70.jpg" alt="survival of mice with subcutaneous xenografts treated with PBS, adenosine virus vector or adensine virus vector coding SARI" />

	<p><em>Chemical Structure of THC</em></p></div>

<p>Maximally-tolerated dose (MTD)  inhalation toxicology studies along with long-term 1-month and 3-month studies  have been completed in both rats and dogs. The results of these studies and kinetic data revealed no development-limiting  findings. All three doses tested in  Phase I were found to be safe and well tolerated. Phase II studies completed in migraine sufferers showed efficacy vs. placebo.</p>

<p class="licensable_tech">Technology Status</p>

  <p>This technology is protected by an extensive patent estate composed of both U.S. and foreign issued patents and patent applications.  Among the aspects covered are the aerosolized formulation of THC, the use of THC in pulmonary delivery, and formulations of THC for pulmonary delivery. (See US patents 6,509,005, 6,713,048)</p>

  <p>This technology is available for licensing to industry for further development and commercialization.</p>

  <p class="licensable_tech">Dosage Form</p>

    <p>Pulmonary THC is  delivered and inhaled via an aerosol cloud formed from a pressurized metered  dose inhaler (pMDI), formulated as a drug solution. The inactive ingredients include dehydrated  alcohol (10%) and HFA 134a propellant (88.0-89.5%). Each pMDI contains 100 actuations of either 0.3 mg (0.5%) or 1.2 mg (2.0%) THC. The  primary closure system is an aluminum canister and metered dose valve, which is  packaged with a polypropylene actuator and dust cap. Pulmonary THC appears to provide faster and  improved systemic delivery of the API. Systematic studies have been performed to optimize the formulation and  fine particle fraction of the aerosol cloud, assess compatibility of packaging components, and evaluate the effects of oxygen and moisture on the stability of the API in the formulated product. </p>

  <p class="licensable_tech">Clinical  Experience with THC pMDI</p>

      <p><em>Phase I &ndash; Three Phase  I Studies Completed </em><br />

    S1751103. This study was a parallel-group, crossover, double-blind, placebo-controlled, single rising dose tolerance study in healthy  volunteers. Six inhaled single dose  levels of 0.3, 1.2, 2.4, 3.6, 7.2, 9.6 mg per puff were used. <u>General Conclusions</u>: Product was safe and tolerated at single  doses between 0.3 and 9.6 mg; psychotropic effects were evident at the 7.2 and  9.6 mg doses; well described heart rate increases occurred at higher doses; systemic absorption was rapid.</p>

      <p>S1751104. This was a double-blind-placebo-controlled,  multiple rising dose tolerability study. Eighteen healthy subjects were enrolled in this pharmacokinetic and  tolerability study of 2 doses (1.2 and 3.6 mg per puff given 3 times daily) for  up to 14 days. <u>General Conclusions</u>: Product was safe and well-tolerated after  single and multiple doses at the 1.2 and 3.6 mg doses; cough was the most  common adverse effect; systemic absorption was rapid. After multiple dosing the effect of  dose-related HR increase was less evident. </p>

        <p>S1751110. This was a double-blind, placebo-controlled multiple dose study of 3 pMDI doses (3.6, 4.8, 6.0 mg/puff) in healthy volunteers. <u>General Conclusions</u>: All three doses were found to be safe and well tolerated.</p>

  <p class="style3"><em>Phase II &ndash; One Study  Completed in Migraine Sufferers</em><br />

    S1752103.  This was a double-blind, placebo-controlled, parallel-group study in 240  migraine sufferers at 1.2, 2.4, 3.6 mg vs. placebo. The treatment was  administered 2 hours within onset followed by assessment of pain response (1&ordm;)  and associated symptoms (nausea, etc.). The adverse effects evaluated included  cardiovascular, nervous system and psychoactive. <u>Headline Results</u>: 3.6  mg dose was effective for symptomatic treatment of nausea; the 2.4 and 3.6 mg  doses providing some pain relief; coughing and throat irritation were most  commonly reported adverse effects; CNS effects were generally low and there  were no significant differences in CV, CNS and psychoactive effects among  active groups, or between active and placebo; there were no unexpected effects.</p>
  
  <!-- InstanceEndEditable -->
      </div><!--end content_text-->
    </div><!--end content-->    
    <div id="right_nav">
    
    	<div class="nav_heading">VP for Research and Innovation &#187;</div>
        	<ul>
        		<li><a href="../../vpr/index.htm">VP for Research and Innovation</a></li>
                <li><a href="../../centers_cores/institutes.htm">Institutes and Centers</a></li>
                <li><a href="../../centers_cores/core_laboratories.htm">Research Cores</a></li>
                <li><a href="../../vpr/research_fund/index.htm">Research Quest Fund</a></li>
                <li><a href="../../vpr/grant_writing/index.htm">Grant Writing Institute</a></li>
                <li><a href="../../research_development/index.htm">Research Development</a></li>
                <li><a href="../../ugresources/index.htm">Undergraduate Research</a></li>
        		<li><a href="../../postdoc/index.htm">Postdoctoral Services</a></li>               
        	</ul>
            
    	<div class="nav_heading">Research Quick Links &#187;</div>
        	<ul>                               
                                
                <li><a href="../../vpr/research_compliance.htm">Research Compliance Matrix</a></li>
                <li><a href="../../vcuera/index.htm">VCUeRA</a></li>
                <li><a href="../../forms/index.htm">Forms</a></li>
                <li><a href="../../events/index.htm">Events</a></li>
                <li><a href="../../policies/index.htm">Policies</a></li>                
                <li><a href="../../vpr/contactus.htm">Contact a Specific Office</a></li>
                <li><a href="http://www.adobe.com/products/acrobat/readstep2.html" target="_blank">Download Adobe Reader</a><!-- #BeginLibraryItem "/Library/pdf_logo.lbi" --><img src="../../graphics/pdf_logo.gif" alt="pdf logo" style="margin-bottom:-.25em;" /><!-- #EndLibraryItem --></li>
        	</ul>
        
     	<div id="helpline">
       	  <a href="http://www.assurance.vcu.edu/reporting.html" target="_blank"><img src="../../images/helpline.jpg" alt="Helpline Image: To report any concern or for more information, (888)242-6022; www.vcuhelpline.com; www.ethicspoint.com" /></a>   	    
        </div>
       	</div><!--end right_nav-->    
    
   <div id="signature">
  		<ul>
    		<li><a href="http://www.vcu.edu" target="_blank">Virginia Commonwealth University</a> | <a href="http://www.research.vcu.edu/" target="_blank">Office of Research and Innovation</a></li>
            <li>800 East Leigh Street  PO Box 980568 Richmond, VA 23298</li>
            <li><a href="mailto:erahelp@vcu.edu?subject=Website%20Comments" target="_blank">Contact Us</a> | Updated: <!-- #BeginDate format:Am3 -->08/13/2014<!-- #EndDate --> | <a href="../../sitemap.htm">Site Map</a> | <a href="http://ts.vcu.edu/cgi-bin/posh.pl">View text-only version</a></li>
     	</ul>
</div><!--end #signature-->

</div><!--end main-->

<div id="vcu_footer">

	<a href="http://www.makeitreal.vcu.edu" target="_blank"><img src="http://identity.vcu.edu/widgets/branding/black/responsive/images/makeitrealFooter.gif" alt="Make It Real" /></a>
    
    <a href="http://www.vcu.edu" target="_blank"><img src="http://identity.vcu.edu/widgets/branding/black/responsive/images/vcubar-footer.gif" alt="Virginia Commonwealth University" /></a>
    
</div>
	
</div><!--end .page-->
</body>
<!-- InstanceEnd --></html>
